Actively Recruiting
Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR"
Led by Institut Pasteur · Updated on 2025-12-15
75
Participants Needed
1
Research Sites
259 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Exclusive breastfeeding during the first six months of life and continued breastfeeding for at least 24 months constitute the optimal feeding method for infants and young children. However, breast milk and breastfeeding can be significant pathways for the transmission of certain viruses. The objective of this study is to examine the influence of human breast milk and its composition on viral infectivity and viral transmission of the HTLV-1 virus and arboviruses such as Zika virus, yellow fever, dengue, and tick-borne encephalitis.
CONDITIONS
Official Title
Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR"
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Female gender
- Donors registered with the Lactarium of Île-de-France
- Covered by a Social Security scheme, excluding State Medical Aid
You will not qualify if you...
- Women opposing participation in the study
- Positive HIV, HBV, HCV, or HTLV serologies (Lactarium exclusion criteria)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lactarium Ile-de-France, Necker-Enfents Malades Hospital
Paris, France, 75015
Actively Recruiting
Research Team
A
Aurore VIDY-ROCHE, PhD
CONTACT
P
Pierre-Emmanuel CECCALDI, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here